We provide you with 20 years of free, institutional-grade data for OCUL stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of OCUL. Explore the full financial landscape of OCUL stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-05 | 1393434 | OCUL | 10-Q | Url |
| 2025-05-05 | 1393434 | OCUL | 10-Q | Url |
| 2025-03-03 | 1393434 | OCUL | 10-K | Url |
| 2024-11-14 | 1393434 | OCUL | 10-Q | Url |
| 2024-08-07 | 1393434 | OCUL | 10-Q | Url |
| 2024-05-07 | 1393434 | OCUL | 10-Q | Url |
| 2024-03-11 | 1393434 | OCUL | 10-K | Url |
| 2023-11-07 | 1393434 | OCUL | 10-Q | Url |
| 2023-08-07 | 1393434 | OCUL | 10-Q | Url |
| 2023-05-08 | 1393434 | OCUL | 10-Q | Url |
| 2023-03-06 | 1393434 | OCUL | 10-K | Url |
| 2022-11-07 | 1393434 | OCUL | 10-Q | Url |
| 2022-08-08 | 1393434 | OCUL | 10-Q | Url |
| 2022-05-09 | 1393434 | OCUL | 10-Q | Url |
| 2022-02-28 | 1393434 | OCUL | 10-K | Url |
| 2021-11-08 | 1393434 | OCUL | 10-Q | Url |
| 2021-08-09 | 1393434 | OCUL | 10-Q | Url |
| 2021-05-05 | 1393434 | OCUL | 10-Q | Url |
| 2021-03-11 | 1393434 | OCUL | 10-K | Url |
| 2020-11-05 | 1393434 | OCUL | 10-Q | Url |
| 2020-08-07 | 1393434 | OCUL | 10-Q | Url |
| 2020-05-08 | 1393434 | OCUL | 10-Q | Url |
| 2020-03-12 | 1393434 | OCUL | 10-K | Url |
| 2019-11-12 | 1393434 | OCUL | 10-Q | Url |
| 2019-08-07 | 1393434 | OCUL | 10-Q | Url |
| 2019-05-10 | 1393434 | OCUL | 10-Q | Url |
| 2019-03-07 | 1393434 | OCUL | 10-K | Url |
| 2018-11-07 | 1393434 | OCUL | 10-Q | Url |
| 2018-08-07 | 1393434 | OCUL | 10-Q | Url |
| 2018-05-08 | 1393434 | OCUL | 10-Q | Url |
| 2018-03-08 | 1393434 | OCUL | 10-K | Url |
| 2017-11-07 | 1393434 | OCUL | 10-Q | Url |
| 2017-08-08 | 1393434 | OCUL | 10-Q | Url |
| 2017-05-05 | 1393434 | OCUL | 10-Q | Url |
| 2017-03-10 | 1393434 | OCUL | 10-K | Url |
| 2016-11-09 | 1393434 | OCUL | 10-Q | Url |
| 2016-08-09 | 1393434 | OCUL | 10-Q | Url |
| 2016-05-10 | 1393434 | OCUL | 10-Q | Url |
| 2016-03-10 | 1393434 | OCUL | 10-K | Url |
| 2015-11-10 | 1393434 | OCUL | 10-Q | Url |
| 2015-08-10 | 1393434 | OCUL | 10-Q | Url |
| 2015-05-20 | 1393434 | OCUL | S-1 | Url |
| 2015-05-15 | 1393434 | OCUL | 10-Q | Url |
| 2015-03-20 | 1393434 | OCUL | 10-K | Url |
| 2014-11-12 | 1393434 | OCUL | 10-Q | Url |
| 2014-08-29 | 1393434 | OCUL | 10-Q | Url |
| 2014-06-20 | 1393434 | OCUL | S-1 | Url |
Ocular Therapeutix, Inc(NASDAQ:OCUL) 
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company markets ReSure Sealant, an ophthalmic device designed to prevent...
Website: http://www.ocutx.com
Founded: 2006
Full Time Employees: 161
CEO: Antony Mattessich
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about OCUL stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.